SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
Clinical trials for SYSTEMIC INFLAMMATORY RESPONSE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC INFLAMMATORY RESPONSE SYNDROME trials appear
Sign up with your email to follow new studies for SYSTEMIC INFLAMMATORY RESPONSE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for dangerous pancreatitis complication
Disease control CompletedThis study tested an experimental drug called CM4620-IE in 21 people with severe pancreatitis that caused body-wide inflammation (SIRS). The goal was to see if the drug is safe and helps control the disease. Participants received the drug plus standard care or standard care alone…
Matched conditions: SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
Phase: PHASE2 • Sponsor: CalciMedica, Inc. • Aim: Disease control
Last updated Apr 29, 2026 05:45 UTC
-
New drug shows promise in helping pancreatitis patients eat again faster
Symptom relief CompletedThis study tested a drug called Auxora in 216 people hospitalized with acute pancreatitis (inflammation of the pancreas) and a related body-wide inflammation called SIRS. Participants received either Auxora or a placebo daily for three days. The main goal was to see if Auxora hel…
Matched conditions: SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
Phase: PHASE2 • Sponsor: CalciMedica, Inc. • Aim: Symptom relief
Last updated Apr 29, 2026 05:46 UTC
-
New malaria drug put to the test in healthy volunteers
Knowledge-focused CompletedThis study tested a new experimental malaria drug called MMV367 in 12 healthy adults. Participants were intentionally infected with a controlled, low-level malaria infection to see how well the drug kills the parasite and how safe it is. The goal was to understand the right dose …
Matched conditions: SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
Phase: PHASE1 • Sponsor: Medicines for Malaria Venture • Aim: Knowledge-focused
Last updated Apr 29, 2026 05:45 UTC